Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Nasal Carbon Dioxide in the Treatment of Mild Headache in Migraineurs

NCT00690716 is registered in ClinicalTrials.gov with Capnia, Inc. as lead sponsor.

NCT NCT00690716
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00690716 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Nasal Carbon Dioxide in the Treatment of Mild Headache in Migraineurs
Lead sponsor
Capnia, Inc.
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2008
Completion date
June 30, 2009
Enrollment
292 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

migraine